1
0
0
(1 - 28 von 32
)
vasopharm's Traumatic Brain Injury Drug Exceeds Expectations in Phase...
pipelinereview.com
Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We are very pleased and surprised by these results. Working closely with world experts in TBI, the
Christian Wandersee, Würzburg - North Data
www.northdata.de
Web19 Nov · Geschäftsführer: Christian Wandersee · Nicht mehr Geschäftsführer (2 Personen) · Anschrift · Name: vpharm Holding GmbH · Satzung · …
vasopharm Announces Enrolment of First Patient In Phase III …
pipelinereview.com
Web6 Sep · Christian Wandersee, Chief Executive Officer of vasopharm, commented: “We welcome the recruitment of the first patient in to this pivotal phase III trial.
vasopharm Closes Series F Financing Round - Bayerns Investor für …
bayernkapital.de
Web”VAS203 has demonstrated safety and tolerability in two clinical Phase I studies with single and repetitive dosing schedules,” added Christian Wandersee, CEO of vasopharm. “In …
vasopharm Completes Patient Enrollment for Phase III
pipelinereview.com
Web30 Jan · Christian Wandersee, Chief Executive Officer of vasopharm, added: " We are delighted to have reached such a significant milestone. We look forward to delivering …
Biotechnology in Bavaria PDF Free Download
docplayer.net
Christian Wandersee Friedrich-Bergius-ring 15 D Würzburg Phone: +49 (0) Fax: +49 (0) Internet: vermicon AG BIotECH AGro, FooD, EnVIronMEnt vermicon AG ...
Company focus: Vasopharm - PharmaTimes Magazine June 2018
www.pharmatimes.com
CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no existing...
Ausgabe Januar Universität Würzburg
www.uni-wuerzburg.de
Weitere Informationen: Christian Wandersee, Geschäftsführer der vasopharm GmbH, T (0931) , Fax (0931) , ...
Deutsche Biotechnologietage PDF Kostenfreier Download
docplayer.org
... Globalisierung und fairer Wettbewerb Technologietransfer heute und morgen Dr. Volker Fitzner, PricewaterhouseCoopers AG WPG Christian Wandersee, ...
People with Surname WANDERSEE living in Germany | Locate-Friend.Com -...
locate-friend.com
People with Surname WANDERSEE living in Germany. Carsten Und Silke Wandersee, Christian Wandersee, Cäcilie Wandersee, Detlef Wandersee, Dirk Wandersee,...
vasopharm BIOTECH GmbH - Bayern International – Exportförderung für...
www.bayern-international.de
vasopharm BIOTECH GmbH Unternehmen. Basisdaten; Produkte/Leistungen; Kontaktpersonen; Karte; Straße: ... Herr Christian Wandersee - Geschäftsführung ...
vasopharm gmbh vasopharm gmbh - das Hersteller- und Lieferanten-...
www.diedeutscheindustrie.de
Auftragsforschung und -entwicklung. Unternehmensleitung. Geschäftsführung. Dr. Frank Tegtmeier Christian Wandersee. Handelsregister. HRB 6241, Würzburg ...
Würzburger Vasopharm erhält 20 Mio. Euro für Phase-III-Studie -...
dev.s4l.welabs.de
Die Daten der vorangegangenen Phase II-Studie seien sehr genau analysiert worden, berichtet Firmenchef Christian Wandersee: „Wir glauben, dass wir mit ...
vasopharm schließt Finanzierungsrunde über EUR 9,5 Millionen ab/...
bayernkapital.de
Christian Wandersee, CEO von vasopharm, kommentierte: „Nach der Empfehlung des Data Monitoring Committee (DMC), die NOSTRA-III-Studie protokollgemäß ...
Abstracts of Research in Marine & Aquatic Education Pages...
fliphtml5.com
Check Pages of Abstracts of Research in Marine & Aquatic Education in the flip PDF version. Abstracts of Research in Marine & Aquatic Education...
Make It Ten: vasopharm. In Make It Ten №5 we spoke with… | by Thomas...
medium.com
· In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV fund. Hopefully, as a ...
Updates: vasopharm announces Last Patient Last Visit in NOSTRA III...
www.creathor.com
· Forfurther information, please contact: vasopharm GmbH. Christian Wandersee, CEO. Tel: + Email: wandersee@vasopharm.
Vasopharm completes patient enrollment for phase 3 traumatic brain...
www.pharmajournalist.com
· Christian Wandersee, Chief Executive Officer of vasopharm, added: “We are delighted to have reached such a significant milestone. We look ...
vasopharm Closes €9.5M Financing Round - FinSMEs
www.finsmes.com
vasopharm, a Wurzburg, Germany-based private bio… company developing a novel treatment for traumatic brain injury, closed a €9.5m financing
vasopharm BIOTECH GmbH Announces Enrollment Of First Patient In Phase...
www.biospace.com
Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal phase ...
vasopharm BIOTECH GmbH Closes Series F Financing Round | BioSpace
www.biospace.com
vasopharm BIOTECH GmbH Closes Series F Financing Round - read this article along with other careers information, tips and advice on BioSpace
vasopharm gmbh vasopharm gmbh - proveedores y fabricantes de
www.deutsche-exportdatenbank.de
Gestión. Dr. Frank Tegtmeier Christian Wandersee. Registro mercantil. HRB 6241, Würzburg. No. de IVA. DE Otros fabricantes y proveedores a: ...
vasopharm Raises €20M in Funding - FinSMEs
www.finsmes.com
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Team - Vasopharm GmbH
www.vasopharm.com
Get to know the vasopharm GmbH team. Get informed about their qualifications, their CV and their tasks within the company.
vasopharm BIOTECH GmbH - Bayern International – Competence for...
www.bayern-international.de
End of validity period: k.A.. Contact person: Dr. Frank Tegtmeier (Mr.) - Management - Research & development. Christian Wandersee (Mr.) - Management ...
Alle Infos zum Namen "Christian Wandersee"
Verwandte Suchanfragen zu Christian Wandersee
Frank Tegtmeier Gabriele Wandersee Peter Hartmann |
Personen Vorname "Christian" (95886) Name "Wandersee" (49) |
sortiert nach Relevanz / Datum